Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y, et al. The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression. PLoS One. 2011;6:e25631.
Article
CAS
PubMed
PubMed Central
Google Scholar
Omar AI. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma. J Vis Exp. 2014;92:e51638.
Google Scholar
Cackowski FC, Wang Y, Decker JT, Sifuentes C, Weindorf S, Jung Y, et al. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer. Prostate. 2019;79(14):1715–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159–68.
Article
PubMed
Google Scholar
Boussiotis VA, Charest A. Immunotherapies for malignant glioma. Oncogene. 2018;37(9):1121–41.
Article
CAS
PubMed
Google Scholar
Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W, Qiao W, et al. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res. 2008;14:5166–72.
Article
CAS
PubMed
Google Scholar
Alexiou GA, Vartholomatos G, Karamoutsios A, Batistatou A, Kyritsis AP, Voulgaris S. Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma. Acta Neurol Belg. 2013;113:7–11.
Article
PubMed
Google Scholar
Wu S, Yang W, Zhang H, Ren Y, Fang Z, Yuan C, et al. The prognostic landscape of tumor-infiltrating immune cells and immune checkpoints in glioblastoma. Technol Cancer Res Treat. 2019;18:1533033819869949.
PubMed
PubMed Central
Google Scholar
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377(14):1345–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, et al. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol. 2018;19(5):672–81.
Article
CAS
PubMed
Google Scholar
Shen-Orr SS, Gaujoux R. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr Opin Immunol. 2013;25(5):571–8.
Article
CAS
PubMed
Google Scholar
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Meth. 2015;12(5):453–7.
Article
CAS
Google Scholar
Ge P, Wang W, Lin L, Zhang G, Gao Z, Tang Z, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. Biomed Pharmacother. 2019;118:109228.
Article
CAS
PubMed
Google Scholar
Zhang S, Zhang E, Long J, Hu Z, Peng J, Liu L, et al. Immune infiltration in renal cell carcinoma. Cancer Sci. 2019;110(5):1564–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang X, Shi Y, Li M, Lu T, Xi J, Lin Z, et al. Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma. J Transl Med. 2019;17(1):217.
Article
PubMed
PubMed Central
Google Scholar
Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11:762–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38:79–91.
Article
CAS
PubMed
Google Scholar
Dal-Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong CH, Petri B, et al. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2 þ monocytes at a site of sterile injury. J Exp Med. 2015;212:447–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM, et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol. 2006;80:59–65.
Article
CAS
PubMed
Google Scholar
Ray R, Rai V. Lysophosphatidic acid converts monocytes into macrophages in both mice and humans. Blood. 2017;129(9):1177–83.
Article
CAS
PubMed
Google Scholar
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment. Cancer Cell. 2017;32(1):42–56.
Article
PubMed
PubMed Central
CAS
Google Scholar
Vinnakota K, Hu F, Ku MC, Georgieva PB, Szulzewsky F, Pohlmann A, et al. Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. Neuro-Oncology. 2013;15:1457–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carding SR, Kyes S, Jenkinson EJ, Kingston R, Bottomly K, Owen JJ, et al. Developmentally regulated fetal thymic and extrathymic T-cell receptor gamma delta gene expression. Genes Dev. 1990;4(8):1304–15.
Article
CAS
PubMed
Google Scholar
Nakasone C, Yamamoto N, Nakamatsu M, Kinjo T, Miyagi K, Uezu K, et al. Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection. Microbes Infect. 2007;9(3):251–8.
Article
CAS
PubMed
Google Scholar
Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, et al. Characterization and immunotherapeuticn potential of gammadelta T-cells in patients with glioblastoma. Neuro-Oncology. 2009;11(4):357–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225–74.
Article
CAS
PubMed
Google Scholar
Chiesa S, Tomasello E, Vivier E, Vely F. Coordination of activating and inhibitory signals in natural killer cells. Mol Immunol. 2005;42:477–84.
Article
CAS
PubMed
Google Scholar
Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004;23:255–9.
Article
CAS
PubMed
Google Scholar
Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107(1):159–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT. TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro-Oncology. 2010 Jan;12(1):7–13.
Article
CAS
PubMed
Google Scholar
Crane CA, Austgen K, Haberthur K, Hofmann C, Moyes KW, Avanesyan L, et al. Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. Proc Natl Acad Sci U S A. 2014;111(35):12823–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol. 2005;5:296–306.
Article
CAS
PubMed
Google Scholar
Lion E, Smits EL, Berneman ZN, Van Tendeloo VF. NK cells: key to success of DC-based cancer vaccines? Oncologist. 2012;17:1256–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baur AS, Lutz MB, Schierer S, et al. Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg. Blood. 2013;122:2185–94.
Article
CAS
PubMed
Google Scholar
Lotfi R, Lee JJ, Lotze MT. Eosinophilic granulocytes and damage associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother. 2007;30:16–28.
Article
CAS
PubMed
Google Scholar
Hayes RL, Arbit E, Odaimi M, Pannullo S, Scheff R, Kravchinskiy D, et al. Adoptive cellular immunotherapy for the treatment of malignant gliomas. Crit Rev Oncol Hematol. 2001;39(1–2):31–42.
Article
CAS
PubMed
Google Scholar
Defendini R, Hunter SB, Schlesinger EB, Leifer E, Rowland LP. Eosinophilic meningitis in a case of disseminated glioblastoma. Arch Neurol. 1981;38(1):52–3.
Article
CAS
PubMed
Google Scholar
Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol. 2006;79(6):1131–9.
Article
CAS
PubMed
Google Scholar
Tehrani M, Friedman TM, Olson JJ, Brat DJ. Intravascular thrombosis in central nervous system malignancies. A potential role in astrocytoma progression to glioblastoma. Brain Pathol. 2008;18(2):164–71.
Article
PubMed
Google Scholar
Koh YI, Lee J-B, Lee S-R, Ji S-G, Choi IS. Relationship between dendritic cells and activated eosinophils in induced sputum of asthmatics. J Korean Med Sci. 2005;20:384–9.
Article
PubMed
PubMed Central
Google Scholar
Janakiram M, Pareek V, Cheng H, Narasimhulu DM, Zang X. Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies. Immunotherapy. 2016;8(7):809–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ward R, Sims AH, Lee LC, Wynne L, Yusuf H, Gregson H, et al. Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment. Oncotarget. 2015;6:14687–99.
PubMed
PubMed Central
Google Scholar
Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 2013;138:105–15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muenst S, Schaerli AR, Gao F, Däster S, Trella E, Droeser RA, et al. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat. 2014;146:15–24.
Article
CAS
PubMed
PubMed Central
Google Scholar